Progression from early- to late-stage MCL is characterized by SPARC and VEGFA overexpression, identified by the comparative analysis and by the pathway enrichment analysis as members of the “miR-509-3p alteration of YAP1/E” and the “VEGF signaling” pathways, respectively. This evidence concerns the gene SPARC and mantle cell lymphoma.